ARCHIVES

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

M.D. Anderson Investigator Gave Drug To Patients Without IND; NCI Probes Incident, To Make Report

July 17, 1981

ACS Survey Finds Need for Cancer Education Among Hispanic Americans

August 2, 1985

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996

Jerome Yates Named VP For Research At ACS

February 8, 2002